Following a year of strong growth and successful acquisitions, Entrust People and SCI Search & Selection are merging to become Entrust Resource Solutions.
This new brand better represents the future of our group of recruitment consultancies and is a massive step towards us realising our vision of providing the very best, fully accountable, bench to board talent solution.
Our merger will enable us to better serve our clients and candidates as one larger, consolidated team strategically positioned in thriving life science hubs across the UK: Dundee, Northwich and our executive search brand…
The next SysMIC Module 1 course will start on Monday 27th April 2020
SysMIC was developed with BBSRC funding and provides introductory and advanced training in mathematics, statistics and computing for bioscientists. SysMIC is a comprehensive online course in interdisciplinary skills in the life sciences with over 2,000 participants enrolling since its beginning in 2013.
Key topics are:
• Network biology
• Mechanistic modeling, and
• Data analysis
Participants will gain an understanding of:
• Programming in Python, MATLAB and R
• Analysing, modelling and simulating biological systems
•…
Cambridge, UK, 13th February 2020 / Sciad Newswire / Domainex Ltd is pleased to announce the appointment of Dr Tom Mander as Chief Executive Officer. Dr Mander will take over when Dr Trevor Perrior retires from the role in April 2020. Tom has nearly 30 years of experience in small-molecule drug discovery, and joined Domainex as Chief Operating Officer in March 2015 with a mandate to achieve organic expansion of the drug discovery service business of the company.
Trevor Perrior, CEO of Domainex, said, “I am very pleased that Tom has agreed to take over as Chief Executive. Tom joined the…
Cambridge, UK, 13 February 2020: Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, today announced investment in the production and supply of its proprietary biocompatible surfactant, Pico-Surf™, for reliable and highly stable droplet generation and processing. Sphere Fluidics will expand operations to meet demand for large-scale commercial supply of its high-performing surfactant for use in a wide range of microfluidic application workflows.
Pico-Surf is a high-quality and animal-origin-free…
CAMBRIDGE, UK and NEW YORK, USA, 10 February 2020 Artios Pharma Limited (Artios), a leading DNA Damage Response (DDR) company developing a broad pipeline of innovative treatments for cancer, today announces the appointment of Bryony Harrop as Vice President (VP) of Clinical Development, Bryony will be working alongside Dr Gillian Langford, also VP of Clinical Development, who joined Artios in January 2019.
Bryony will report directly to Chief Medical Officer, Dr Ian Smith, and in collaboration with Gillian will be responsible for the clinical development strategy, regulatory, and…
LOUGHBOROUGH, England (February 3, 2020) – Thermo Fisher Scientific, the world leader in serving science, recently announced the winners of the Fisher Scientific Channel Supplier Awards during its annual Fisher Scientific European Sales Conference held in Madrid.
From January 27-30, 2020, a total of 817 delegates attended the Fisher Scientific European Sales Conference at the Melia Castilla hotel in Madrid. This was the ninth event of its kind, bringing together delegates from 23 different countries.
The event, themed Lead with Purpose, included an exhibition showcase with 65 booths featuring…
With the transition period for the new European Medical Device Regulation (EU) 2017/745 (MDR) coming to an end in May 2020, it is imperative that manufacturers take action to update their technical documentation and processes to meet the new requirements.
The MDR, which replaces the Medical Devices Directive (93/42/EEC), brings with it more scrutiny of technical documentation, addressing concerns over the assessment of product safety and performance by placing stricter requirements on clinical evaluation and post-market clinical follow-up and requiring better traceability of devices through…
- Dr Anthony Hall joins at pivotal time, ahead of fragile X syndrome clinical trial initiation.
- Findacure co-founder will apply extensive drug repurposing and rare disease expertise to progress Healx’s drug candidates into the clinic.
Cambridge, UK – 4 February 2020 – Healx, the AI-powered and patient-inspired technology company specialising in finding new treatments for rare diseases, today announced the appointment of Dr Anthony Hall, MB BS BSc, as Chief Medical Officer (CMO). Tony will be responsible for progressing the company’s rare disease drug candidates through the clinic, with an…
Cambridge, UK, 03 February 2020: PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has made two appointments to strengthen its leadership team, as the Company positions itself for growth. Dr Catherine Beech joins the PhoreMost Board as a Non-Executive Director. Dr Benedict (Ben) Cross has joined as Senior Director (Technology), and will direct the evolution and development of the Company’s SITESEEKER® screening platform.
Catherine has over 25 years of biotech and pharmaceutical industry experience, including…
As the growing demand for personalised medicines continues, a recent report projects that the global growth of the Advanced Therapy Medical Products (ATMPs) market will also be boosted.
This creates tremendous potential for patients and the industry alike.
Currently there are a small number of licensed products, with many more undergoing clinical trials. In addition to this, there are numerous projects in late phase development about to enter the clinical trial phase.
Current guidance has struggled to keep up with the rapid expansion of this area of product development in the…